Seeking Alpha: Endo Pharmaceuticals Playing An Unconventional Hand

Although many well-known medical device franchises can trace their roots back to Big Pharma, most of those companies jettisoned their device companies in a wave of divestitures in the 1980's and 90's. More recently, Abbott Labs (ABT) has decided to separate its drug and device businesses, while pressure mounts for Medtronic (MDT) to ponder splitting its slow-growth and high-growth businesses.

So of course Endo Pharmaceuticals (ENDP), once a specialist in pain and urology drugs, decides to buy some slow-growth device businesses and build itself into a triple-threat of drugs, devices, and generics. While the company did take on quite a lot of debt to restructure itself, time may prove that diversification was the right move.

Please click here for the full article:
Endo Pharmaceuticals Playing An Unconventional Hand